Rovalta
Understanding a Belgian company shouldn't take hours.
Yves Rocher Belgique (0405.912.732) — Belgian company profile — Rovalta
Info Key figures Directors & structure Annual accounts Publications Similar companies Timeline
Frequently asked questions Key figures
Financial data Table Chart
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2009 Revenue 55,2 M € -6.5%59,1 M € -1.5%60,0 M € -0.8%60,5 M € -2.1%61,8 M € +18.2%52,3 M € -15.0%61,5 M € -0.1%61,6 M € -3.3%63,7 M € +0.8%63,2 M € +0.0%63,2 M € +3.6%61,0 M € +1.9%59,8 M € -1.0%60,4 M € +20.1%50,3 M € EBITDA 2,9 M € +252.2%-1,9 M € -644.2%346,3 k € -45.4%634,2 k € -72.4%2,3 M € +1389.4%-178,4 k € -107.2%2,5 M € -30.3%3,5 M € -12.3%4,0 M € -15.0%4,7 M € -16.7%5,7 M € +7.5%5,3 M € -21.7%6,8 M € +21.0%5,6 M € +97.5%2,8 M € Operating profit 1,4 M € +135.6%-4,0 M € -204.8%-1,3 M € +10.2%-1,5 M € -197.7%-493,7 k € +78.5%-2,3 M € -1023.4%248,4 k € -80.0%1,2 M € -11.9%1,4 M € -20.6%1,8 M € -19.7%2,2 M € +32.0%1,7 M € -44.0%3,0 M € +48.4%2,0 M € +465.1%355,9 k € Profit/loss 1,5 M € +142.1%-3,6 M € -263.3%-1,0 M € +35.8%-1,6 M € -87.1%-834,6 k € +61.9%-2,2 M € -584.0%-320,4 k € -139.6%809,1 k € -29.3%1,1 M € -49.5%2,3 M € +44.9%1,6 M € +33.6%1,2 M € -47.4%2,2 M € +43.1%1,6 M € +1406.1%-119,1 k € Equity 1,7 M € +1155.5%132,6 k € -96.4%3,6 M € -21.6%4,6 M € +286.3%1,2 M € -41.0%2,0 M € -67.3%6,2 M € -4.9%6,5 M € -32.8%9,7 M € -28.4%13,6 M € +3.9%13,1 M € +0.5%13,0 M € +9.9%11,8 M € +23.2%9,6 M € +57.0%6,1 M € Total assets 14,7 M € -17.9%17,9 M € -3.6%18,6 M € -3.8%19,3 M € +8.8%17,8 M € -10.7%19,9 M € -7.9%21,6 M € -13.8%25,1 M € -16.4%30,0 M € -2.5%30,8 M € -25.6%41,3 M € +5.1%39,3 M € +39.7%28,2 M € -3.5%29,2 M € +1.7%28,7 M € Cash 468,3 k € +152.4%185,5 k € -47.7%354,7 k € +14.5%309,8 k € -4.5%324,5 k € +153.1%128,2 k € -72.5%467,1 k € +40.1%333,3 k € +55.3%214,6 k € +40.0%153,3 k € +0.5%152,5 k € -31.8%223,7 k € +39.5%160,3 k € -85.7%1,1 M € -44.1%2,0 M € Debts 12,4 M € -26.7%16,9 M € +18.4%14,3 M € +3.3%13,8 M € -11.8%15,7 M € +1.3%15,5 M € +15.4%13,4 M € -23.7%17,6 M € -9.4%19,4 M € +20.0%16,1 M € -40.9%27,3 M € +7.2%25,5 M € +66.4%15,3 M € -17.1%18,5 M € -14.7%21,7 M € Staff 53,2 73,2 94 114,4 207,4 231,6 240,2 255,5 253 230,5 195,3 181,9 174,1 177 203,5
Belgian Official Gazette publications Belgian Official Gazette publications View the 58 publications
Name history YVES ROCHER BELGIQUE SA 2024–2025 Laboratoire de Biologie Végétale Yves Rocher 2022–2023 LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER SA 2021 Competition
Similar companies Other companies at this address Other companies at this address ACTIVEBCE 0405.912.732 Public limited company Full model NBB ✓
YR
Yves Rocher Belgique Public limited company · Tournai · incorporated on 14/08/1968 · 53,2 ETP
Equity
1,7 M €
solvency 11,3 %
Health score
Z-Score 3.1
NSSO & social debts 9,8 % Recommended credit limit€ 1.30M
Maximum recommended credit amount, based on solvency, liquidity and profitability.
Available with a free account ✦ Verdict · Analyst summaryPublic limited company profitable and well capitalised . Cash position rising (+152.4%).
Recommendation
Solid counterparty for a standard engagement.
Financial overview
Financial year 2025 Frequently asked questionsWhat is the VAT number of Yves Rocher Belgique?
Where is Yves Rocher Belgique located?
What type of company is Yves Rocher Belgique?
When was Yves Rocher Belgique founded?
What profit did Yves Rocher Belgique make in 2025?
How much debt did Yves Rocher Belgique have in 2025?
What does Yves Rocher Belgique do? Yves Rocher Belgique is a Public limited company incorporated in 1968. Its main activity is: Manufacture of perfumes and toilet preparations. Its registered office is in Tournai. It employs on average 53,2 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0405.912.732
Legal form
Public limited company
Registered office
Rue du Follet(K) 50
7540 Tournai · Wallonie
See on mapContribution (capital)
5 805 200,00 €
Accounts model
Full model · French
Latest accounts
31/12/2025
Average workforce
53,2 ETP
Annual accountsFinancial health ratios Key indicators
Looking for more information about this company? Check its health at a glance Choose quick info or granular detail Get updates on important developments 7-day free trial, no credit card required.
Looking for more information about this company? Check its health at a glance Choose quick info or granular detail Get updates on important developments 7-day free trial, no credit card required.
Looking for more information about this company? Check its health at a glance Choose quick info or granular detail Get updates on important developments 7-day free trial, no credit card required.
Timeline 2025
Annual accounts 2025 1,5 M €↑
2024
Annual accounts 2024 -3,6 M €↓
2024
Name change YVES ROCHER BELGIQUE SA
2023
Annual accounts 2023 -1,0 M €↑
2022
Annual accounts 2022 -1,6 M €↓
2022
Name change Laboratoire de Biologie Végétale Yves Rocher
Mandates 25/07/2025
DEMISSIONS, NOMINATIONS PDF Mandates 22/04/2025
DEMISSIONS, NOMINATIONS PDF Mandates 08/05/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS,
) - DENOMINATION PDF Mandates 22/04/2024
DEMISSIONS, NOMINATIONS PDF Restructuring 11/03/2024
OBJET - CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) PDF Restructuring 03/01/2024
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) PDF Other 29/11/2023
ASSEMBLEE GENERALE PDF Mandates 16/05/2023
DEMISSIONS, NOMINATIONS - DIVERS PDF Source: Belgian Official Gazette
Annual accounts 2021 -834,6 k €↑
2021
Name change LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER SA
2020
Annual accounts 2020 -2,2 M €↓
2019
Annual accounts 2019 -320,4 k €↓
2018
Annual accounts 2018 809,1 k €↓
2017
Annual accounts 2017 1,1 M €↓
2016
Annual accounts 2016 2,3 M €↑
2015
Annual accounts 2015 1,6 M €↑
2014
Annual accounts 2014 1,2 M €↓
2013
Annual accounts 2013 2,2 M €↑
2012
Annual accounts 2012 1,6 M €↑
2009
Annual accounts 2009 -119,1 k €
14/08/1968
Incorporation Public limited company
Profitable Positive cashflow Positive EBITDA Healthy social debts High revenue